Structured evidence table for Omega-3 Lipid Profile Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Omega-3 Lipid Profile Meta-Analysis | This escalation is strongly associated with ageing populations, obesity, sedentary lifestyles, and improved survival of diabetic patients due to advances in early detection and therapeutic management []. | 1 | Ghoflchi Sahar (2026) | Evaluating the Effects of Nanocurcumin Supplementation in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials |
| Omega-3 Lipid Profile Meta-Analysis | By reducing curcumin to nanoscale particles, these formulations significantly enhance solubility, absorption and plasma retention, resulting in improved bioavailability and therapeutic efficacy [,,,]. | 1 | Ghoflchi Sahar (2026) | Evaluating the Effects of Nanocurcumin Supplementation in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials |
| Omega-3 Lipid Profile Meta-Analysis | 22 The methodological quality of the included RCTs was evaluated using the Cochrane Risk of Bias tool, which includes seven domains included random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, completeness of data analysis, selective outcome reporting and other potential sources of bias. | 1 | Ghoflchi Sahar (2026) | Evaluating the Effects of Nanocurcumin Supplementation in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials |
| Omega-3 Lipid Profile Meta-Analysis | 1 2 1 2 3 4 5 6 7 8 Type 2 diabetes mellitus (T2DM) is a progressive and multifactorial metabolic disorder characterized by chronic hyperglycemia, insulin resistance and β‐cell dysfunction, and it accounts for nearly 90% of all diabetes cases worldwide [,]. | 1 | Ghoflchi Sahar (2026) | Evaluating the Effects of Nanocurcumin Supplementation in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials |
| Omega-3 Lipid Profile Meta-Analysis | However, conventional soybean oil-based emulsions, which are rich in omega-6 fatty acids, are associated with a risk of exacerbating pro-inflammatory responses and immunosuppression, which is of particular importance in critically ill patients. | 4 | Kęska M (2026) | Fish Oil-Containing Injectable Lipid Emulsions in Parenteral Nutrition: Immunomodulation and Clinical Outcomes in Critically Ill Patients-Narrative Review. |
| Omega-3 Lipid Profile Meta-Analysis | The cited meta-analyses and clinical studies indicate that omega-3-containing emulsions may reduce the risk of infections and sepsis; shorten hospital stay, ICU length of stay, and duration of mechanical ventilation in patients with sepsis; as well as improve outcomes in acute pancreatitis; lower the risk of delirium; and reduce the incidence of delayed gastric emptying. | 4 | Kęska M (2026) | Fish Oil-Containing Injectable Lipid Emulsions in Parenteral Nutrition: Immunomodulation and Clinical Outcomes in Critically Ill Patients-Narrative Review. |
| Omega-3 Lipid Profile Meta-Analysis | Conclusions Available data support the use of mixed-oil ILE supplemented with fish oil in the parenteral nutrition of critically ill patients as a strategy with immunomodulatory and pro-resolving potential that may translate into improved clinical outcomes. | 4 | Kęska M (2026) | Fish Oil-Containing Injectable Lipid Emulsions in Parenteral Nutrition: Immunomodulation and Clinical Outcomes in Critically Ill Patients-Narrative Review. |
| Omega-3 Lipid Profile Meta-Analysis | Background and aims Injectable lipid emulsions are an integral component of parenteral nutrition, providing energy as well as essential fatty acids. | 4 | Kęska M (2026) | Fish Oil-Containing Injectable Lipid Emulsions in Parenteral Nutrition: Immunomodulation and Clinical Outcomes in Critically Ill Patients-Narrative Review. |
Source documents